Ardelyx (ARDX) Long-Term Investments (2020)

Ardelyx's (ARDX) quarterly Long-Term Investments came in at $2.1 million in Q4 2020.

Ardelyx (ARDX) Long-Term Investments (2020) Analysis & Trends

Ardelyx (ARDX) has 1 years of Long-Term Investments data on file, last reported at $2.1 million in Q4 2020.

Quarterly Long-Term Investments changed N/A year-over-year to $2.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.1 million (changed N/A YoY) and the FY2020 annual result came in at $2.1 million, changed N/A from the prior year.
Long-Term Investments was little changed at $2.1 million in Q4 2020.
In the past five years, Long-Term Investments ranged from a high of $2.1 million in Q4 2020 to a low of $2.1 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	5.79 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	9.83 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	372.10 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	22.17 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Ardelyx	1.01 Bn	729.71 Mn	115.12 Mn	-

Download Data

Date	Value
Dec 31, 2020	2.11 Mn